Why the study?
The role of rotational atherectomy is expanding to include certain chronic total occlusion lesions, but long-term outcomes of rotational atherectomy in chronic total occlusions remain unclear.
Does rotational atherectomy for calcified chronic total occlusion (CTO) lesions result in comparable in-hospital and long-term outcomes compared to non-CTO calcified lesions?
Does rotational atherectomy for calcified chronic total occlusion (CTO) lesions result in comparable in-hospital and long-term outcomes compared to non-CTO calcified lesions?
Rotational atherectomy for calcified CTO lesions yields high procedural success and comparable in-hospital outcomes to non-CTO lesions, though long-term target lesion failure is higher due to increased cardiac mortality.
RA in calcified CTO shows comparable safety and outcomes to non-CTO; extends observational data but leaves open need for RCTs.
Background. The role of rotational atherectomy (RA) in contemporary percutaneous coronary intervention (PCI) is expanding to include certain chronic total occlusion (CTO) lesions. However, the long-term outcome of RA in CTOs is still unclear. Objective. To investigate in-hospital and long-term outcomes after RA for CTO compared to non-CTO calcified lesions. Moreover, this report evaluates the role of the elective RA approach in calcified CTOs. Methods and Results. This study enrolled 812 patients (869 lesions; CTO, n = 80 versus non-CTO, n = 789). The mean age of the study population was 73.1 ± 8.6 years, the baseline characteristics were comparable in both groups. Balloon-resistant CTO lesions represented the main indication for RA in CTO patients (61.2%). The mean J-CTO score was 2.42 ± 0.95. The angiographic success rate was lower in CTO patients (88.8% vs 94.9%; p = 0.022). In-hospital major adverse cardiac events (MACE) rate was comparable in both groups (CTO 8.8% vs 7.0% in non-CTO;p = 0.557). At two-year follow-up, a higher target lesion failure (TLF) was observed in CTO group (25.5% vs 15.1%, log rank p = 0.041), driven by higher cardiac mortality while the clinically driven target lesion revascularisation (TLR) was comparable between the study groups. Elective RA for CTO had a shorter procedural time and lower rate of dissection (7.5% vs 25%; p = 0.030) compared to bail-out RA with similar long-term outcomes. Conclusion. Compared to non-CTO, RA for CTO can be performed with a high procedural success rate and comparable in-hospital outcomes. Apart from higher cardiac mortality in the CTO group, the long-term outcomes are comparable in both groups. Elective RA is a feasible and beneficial approach to be used in CTO intervention.
No takes yet. Share an insight, caveat, or question.
Elbasha et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: